AIDS Treatment Access Program ATAP is designed to provide health-care providers and HIV-infected individuals with HIV/AIDS treatment planning and medication resource management. ATAP conducts a continual nationwide HIV/AIDS medication collection outreach effort. ATAP collects ARVs, antibiotics and numerous other medications for the treatment of AIDS-related conditions. Our donors are people who have a surplus of medication because they have changed their therapy, have discontinued their use or have died. These un-expired medications are then sent to ATAP clients in their native countries in collaboration with and direct supervision of their health care providers. A three-month advance inventory is maintained for each client in order to assure continuity of medical care. ATAP has four active programs: 1. Latin America AIDS Program is currently providing antiretroviral therapy to 180 clients in Brazil, Bolivia, Chile, Colombia, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Peru and Venezuela. 2. Caribbean AIDS Program is currently providing antiretroviral therapy to 41 clients in Barbados, Cuba, Dominican Republic, Haiti, Jamaica and Trinidad. 3. African AIDS Program is currently providing antiretroviral therapy to 83 clients in Burundi, Ethiopia, Mali, Uganda, Kenya, South Africa and Zimbabwe. 4. Medicine Collection Division: All recycled medications are received, catalogued and distributed by the Medicine Collection Division. ATAP Enrollment Criteria: To qualify for ATAP, patients must certify that they meet the following minimum medical criteria: • Clients must not have any other source from which medications can be obtained. These include private funds or foundations, social security, or other drug-recycling programs. • Patients must have fewer than 250 CD4+ cell count testing with a lab report generated within three months prior to enrollment. If CD4+ cell count testing is not locally available, blood can be shipped to a lab that can perform the test. AID FOR AIDS intake staff routinely contacts the medical laboratories to confirm all CD4+ count results. • Clients with higher CD4+ counts may be eligible if they can document viral load greater than 50,000 copies/mL within three months prior to submitting an enrollment application. (Note: viral load assays are not routinely available in Africa, the Caribbean and Latin America.) • Any patient with one or more documented opportunistic infections may qualify without immediate CD4+ cell count testing. • Periodic CD4+ cell count testing is required to maintain a continual supply of donated drugs. More Enrollment Criteria >>